MoneyWorks4Me

Bharat Parenterals - Quaterly Results

28 Jul 2025 Evaluate
The company's total revenue for the quarter ended June 2025 saw a slight change in the total revenue, having registered a total revenue of Rs. 943.70 millions.The Company's Net profit for the June 2025 quarter have declined marginally to Rs. 100.00  millions as against Rs. 121.80 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 168.80 millions from 188.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 943.70 920.60 2.51 943.70 920.60 2.51 3041.30 2579.80 17.89
Other Income 16.20 39.00 -58.46 16.20 39.00 -58.46 145.50 80.40 80.97
PBIDT 168.80 188.80 -10.59 168.80 188.80 -10.59 481.50 410.00 17.44
Interest 14.20 10.20 39.22 14.20 10.20 39.22 47.90 38.00 26.05
PBDT 154.60 178.60 -13.44 154.60 178.60 -13.44 433.60 372.00 16.56
Depreciation 20.60 16.10 27.95 20.60 16.10 27.95 70.50 64.00 10.16
PBT 134.00 162.50 -17.54 134.00 162.50 -17.54 363.10 308.00 17.89
TAX 34.00 40.70 -16.46 34.00 40.70 -16.46 98.60 82.10 20.10
Deferred Tax -3.00 -2.70 11.11 -3.00 -2.70 11.11 -7.20 -4.50 60.00
PAT 100.00 121.80 -17.90 100.00 121.80 -17.90 264.50 225.90 17.09
Equity 68.90 65.24 5.61 68.90 65.24 5.61 68.90 58.20 18.38
PBIDTM(%) 17.89 20.51 -12.78 17.89 20.51 -12.78 15.83 15.89 -0.38
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..